{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:41:07Z","timestamp":1793745667086,"version":"4.6.1"},"reference-count":83,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"This research is part of the project ATHENA (Assays for the identification of Thyroid Hormone axis-disrupting chemicals.","award":["CRC\/TR 296 Locotact P16"],"award-info":[{"award-number":["CRC\/TR 296 Locotact P16"]}]},{"name":"This research is part of the project ATHENA (Assays for the identification of Thyroid Hormone axis-disrupting chemicals.","award":["grant number 825161"],"award-info":[{"award-number":["grant number 825161"]}]},{"name":"Deutsche Forschungsgemeinschaft","award":["DFG CRC\/TR 296 Locotact P16"],"award-info":[{"award-number":["DFG CRC\/TR 296 Locotact P16"]}],"id":[{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Deutsche Forschungsgemeinschaft","award":["EU Horizon 2020 Programm, grant # 825161"],"award-info":[{"award-number":["EU Horizon 2020 Programm, grant # 825161"]}],"id":[{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Deutsche Forschungsgemeinschaft","award":["State of Berlin, D; 2021 Prize of the state of Ber"],"award-info":[{"award-number":["State of Berlin, D; 2021 Prize of the state of Ber"]}],"id":[{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]},{"name":"EU Horizon 2020","award":["ATHENA (Assays for the identification of Thyroid H"],"award-info":[{"award-number":["ATHENA (Assays for the identification of Thyroid H"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Thyroid\u00ae"],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Thyroid hormone (TH) homeostasis depends on the coordination of several key events to maintain proper local TH signaling, including iodide uptake, hormone synthesis, metabolism, and elimination. Three selenoprotein isoenzymes, deiodinases 1\u20133 (DIO1\u20133), are essential components of TH metabolism, and their activities have been identified as relevant endpoints regarding the screening of compounds influencing the TH system. Given the importance of DIO2 as the key enzyme for local activation of the prohormone T4 to the active T3 in various tissues, and limited data on selective biochemical DIO2 inhibition, there is a clear need to identify potent and selective DIO2-inhibiting compounds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Human-recombinant DIO2 enzyme pools were prepared from HEK293 cells overexpressing DIO2 and used as a robust enzyme source for the development, optimization, and semiautomated miniaturization of a nonradioactive DIO2 high-throughput screening (HTS) enzyme assay for the identification of DIO2-selective small molecule inhibitors. LT4 was used as substrate, and enzymatic release of iodide was colorimetrically quantified by the iodide-catalyzed Sandell\u2013Kolthoff reaction. Eight comprehensive small molecule libraries were screened, covering \u223c1\/5 of the synthetic chemicals currently registered, natural products, as well as FDA-approved drugs. A total of 59,928 compounds were first screened at a single 10 \u00b5M concentration, followed by a validation screen to confirm the primary hits. Subsequently, DIO isoenzyme selectivity and cytotoxicity were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Utilizing this highly reproducible and robust HTS test system with a determined median Z\u2032-factor of 0.70 identified 356 primary inhibitory hits. Concentration-response experiments verified 17 potent inhibitors, further characterized regarding their DIO isoenzyme selectivity and cytotoxicity. Six potent DIO2-selective inhibitors, including two FDA-approved drugs and various novel pan-DIO inhibitors, for example, the fungicide fluazinam, were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      Specific DIO2 inhibitors, such as the FDA-approved drugs racecadotril and ibrutinib and the tyrosine kinase inhibitor rociletinib, might serve as a future toolbox for reversible pharmacological interference with the local provision of DIO2-generated T3 from T4 during development, tissue regeneration, and various DIO2-dependent metabolic processes. Furthermore, they can serve as reference compounds for the development and validation of regulatory\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      tests. Identified FDA-approved drugs warrant a closer look at potential disturbances of local TH availability.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10507256261425689","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:51:41Z","timestamp":1773391901000},"page":"451-462","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel Deiodinase 2-Selective Inhibitors\u2014Possible Reference Substances for Regulatory\n                    <i>In Vitro<\/i>\n                    Tests for Endocrine Disruptors and Drugs Targeting T3-Dependent Processes"],"prefix":"10.1177","volume":"36","author":[{"given":"Caroline","family":"Fr\u00e4drich","sequence":"first","affiliation":[{"name":"Charit\u00e9-Universit\u00e4tsmedizin Berlin, Institut f\u00fcr Experimentelle Endokrinologie, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Wiese","sequence":"additional","affiliation":[{"name":"Charit\u00e9-Universit\u00e4tsmedizin Berlin, Institut f\u00fcr Experimentelle Endokrinologie, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Charit\u00e9-Universit\u00e4tsmedizin Berlin, Institut f\u00fcr Experimentelle Endokrinologie, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajas","family":"Sane","sequence":"additional","affiliation":[{"name":"Charit\u00e9-Universit\u00e4tsmedizin Berlin, Institut f\u00fcr Experimentelle Endokrinologie, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Fischbach","sequence":"additional","affiliation":[{"name":"Charit\u00e9-Universit\u00e4tsmedizin Berlin, Institut f\u00fcr Experimentelle Endokrinologie, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva K.","family":"Wirth","sequence":"additional","affiliation":[{"name":"Charit\u00e9-Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, Department of Endocrinology and Metabolism, European Reference Network on Rare Endocrine Diseases (ENDO-ERN), Germany, Berlin, Germany."},{"name":"DZHK Partner Site Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Neuenschwander","sequence":"additional","affiliation":[{"name":"Screening Unit, Leibniz-Forschungsinstitut f\u00fcr Molekulare Pharmakologie (FMP), Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Peter","family":"von Kries","sequence":"additional","affiliation":[{"name":"Screening Unit, Leibniz-Forschungsinstitut f\u00fcr Molekulare Pharmakologie (FMP), Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Seyffarth","sequence":"additional","affiliation":[{"name":"Screening Unit, Leibniz-Forschungsinstitut f\u00fcr Molekulare Pharmakologie (FMP), Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Kleissle","sequence":"additional","affiliation":[{"name":"Screening Unit, Max-Delbr\u00fcck-Centrum f\u00fcr Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC), Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostja","family":"Renko","sequence":"additional","affiliation":[{"name":"German Centre for the Protection of Laboratory Animals (Bf3R), German Federal Institute for Risk Assessment, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"K\u00f6hrle","sequence":"additional","affiliation":[{"name":"Charit\u00e9-Universit\u00e4tsmedizin Berlin, Institut f\u00fcr Experimentelle Endokrinologie, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00030.2013"},{"key":"e_1_3_4_3_2","volume-title":"Thyroid Hormones in Brain Development and Function","author":"Bernal J","year":"2022","unstructured":"Bernal J. Thyroid Hormones in Brain Development and Function. MDText.com, Inc.; South Dartmouth (MA), USA; 2022."},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201601116"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2017.06.014"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315113"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2022.09.024"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0218-2"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00275"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab091"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.23.1.38"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab151"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307402101"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093123"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/10408444.2023.2231033"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0076-6879(02)47014-0"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000497141"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/bf01476194"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1863"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0058"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2025.0036"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-009-9187-z"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/108705719900400206"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146021"},{"key":"e_1_3_4_25_2","volume-title":"Konstanz Information Miner\u201d (KNIME) software","author":"Berthold MRC","year":"2007","unstructured":"Berthold MRC, , Dill N, , Gabriel F.\u201d, et al. Konstanz Information Miner\u201d (KNIME) software. Springer: Berlin & Heidelberg, Germany; 2007."},{"key":"e_1_3_4_26_2","unstructured":"Team RC. _R: A Language and Environment for Statistical Computing. Vienna; 2024. Available from: https:\/\/www.R-project.org\/"},{"key":"e_1_3_4_27_2","unstructured":"Promega. Promega CellTox\u2122 Green Cytotoxicity Assay. Madison WI USA; 2023. Available from: https:\/\/www.promega.de\/-\/media\/files\/resources\/protocols\/technical-manuals\/101\/celltox-green-cytotoxicity-assay-protocol.pdf?rev=c1e102d228354d2b81d349f906296f90&sc_lang=en"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059040-00010"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108242"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S97644"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2016.1162786"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2017.4904"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2567"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0177"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00429-019-01896-8"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0303-7207(99)00040-4"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030715"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201600715R"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.09.069"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1530\/etj-24-0315"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1172\/Jci13803"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1113\/JP272440"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI43670"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-021-00511-4"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2038994"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2008.04.009"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106685"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4447"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.15.3"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137364"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2464652"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0351"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0639"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.6b00135"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1055\/a-1175-4610"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.est.9b06379"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2021.106616"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfy302"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2021.105141"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfx279"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2023.105762"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom14111373"},{"key":"e_1_3_4_63_2","first-page":"42","article-title":"Biochemical characteristics of iodothyronine monodeiodination by rat liver microsomes: The interaction between iodothyronine substrate analogs and the ligand binding site of the iodothyronine deiodinase resembles that of the TBPA-iodothyronine ligand binding","volume":"14","author":"K\u00f6hrle J","unstructured":"K\u00f6hrle J, , Hesch RD. Biochemical characteristics of iodothyronine monodeiodination by rat liver microsomes: The interaction between iodothyronine substrate analogs and the ligand binding site of the iodothyronine deiodinase resembles that of the TBPA-iodothyronine ligand binding. Horm Metab Res (Suppl 1984); 14:42\u201355.","journal-title":"Horm Metab Res (Suppl 1984)"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M305725200"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2005.15.787"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105361"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1323873111"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1530\/JME-15-0156"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0924-8579(99)00152-1"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.4"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0198"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1179\/2295333715y.0000000065"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2020.11.025"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.81.P258"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.21040\/eom\/2016.2.2.3"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2023.03.009"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1837"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2022.1048900"},{"key":"e_1_3_4_79_2","article-title":"Commission Regulation (EU) 2023\/464 of 3 March 2023 amending, for the purpose of its adaptation to technical progress, the Annex to Regulation (EC) No 440\/2008 laying down test methods","author":"Commission E","year":"2023","unstructured":"Commission E. Commission Regulation (EU) 2023\/464 of 3 March 2023 amending, for the purpose of its adaptation to technical progress, the Annex to Regulation (EC) No 440\/2008 laying down test methods. Official Journal of the European Union L 68\/37: Brussels, 2023.","journal-title":"Official Journal of the European Union L 68\/37: Brussels"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2025.154157"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfaf141"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101562"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2013.02.012"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1289\/EHP5297"}],"container-title":["Thyroid\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10507256261425689","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10507256261425689","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10507256261425689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:45:16Z","timestamp":1793285116000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10507256261425689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"alternative-id":["10.1177\/10507256261425689"],"URL":"https:\/\/doi.org\/10.1177\/10507256261425689","relation":{},"ISSN":["1050-7256","1557-9077"],"issn-type":[{"value":"1050-7256","type":"print"},{"value":"1557-9077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]}}}